期刊文献+

王不留行黄酮苷改善糖尿病肾病小鼠肠道菌群紊乱和肾脏脂质沉积的研究

Study on vaccarin in improving intestinal flora disorder and renal lipid deposition in diabetes nephropathy mice
原文传递
导出
摘要 目的研究王不留行黄酮苷(Vac)对糖尿病肾病小鼠肾脏脂质合成的影响及其机制。方法通过高脂饲料喂养和腹腔注射链脲佐菌素构建糖尿病肾病小鼠模型。小鼠随机分为正常组、模型组和治疗组。采用血糖仪检测小鼠空腹血糖;采用试剂盒检测小鼠尿液中尿素氮、尿肌酐、24 h尿蛋白、尿蛋白肌酐等的含量,血清中血肌酐、甘油三酯、总胆固醇、低密度脂蛋白、高密度脂蛋白等的含量,肾脏组织中甘油三酯和总胆固醇的含量;采用HE和PAS染色法观察小鼠肾脏的病理学变化;采用总胆汁酸试剂盒测定小鼠血清中总胆汁酸的含量;通过实时荧光定量PCR、免疫印迹和免疫组化分别检测小鼠肾脏组织中固醇调节元件结合蛋白-1和脂肪酸合成酶的mRNA表达,法尼醇X受体(FXR)和G蛋白偶联胆汁酸受体5(TGR5)的mRNA和蛋白表达水平。结果与正常组比较,模型组小鼠的血糖升高、血脂增加,肾脏脂质沉积加剧,肾功能出现损伤;经Vac治疗后,糖尿病肾病小鼠可缓解脂质代谢紊乱,改善小鼠的肾脏功能。模型小鼠的肠道菌群失调,在门和属水平上的有益菌减少,有害菌增加;Vac干预可明显改善了这一情况,同时Spearman相关性分析也显示小鼠脂质代谢水平与肠道菌群存在显著相关性。与正常组比较,模型组小鼠血清中总胆汁酸的含量增加,胆汁酸受体FXR和TGR5受体的表达显著降低;Vac可降低总胆汁酸的含量,上调FXR和TGR5受体的表达。结论Vac可通过调节肠道菌群微生物及其代谢物胆汁酸的水平,缓解模型小鼠脂质沉积,可能是改善糖尿病肾病患者肾脏脂质沉积的有效候选药物。 OBJECTIVE To study the effect of vaccarin(Vac)on renal lipid synthesis in diabetes nephropathy mice and its mechanism.METHODS The diabetic nephropathy(DN)mice model was established by feeding high-fat diet and intraperitoneal injection of streptozocin.The mice were randomly divided into three groups:normal group,diabetes nephropathy model group and Vac treatment group.A glucometer was used to detect fasting blood glucose in mice.The kits were used to detect urea nitrogen,urinary creatinine,24 h urinary protein and urinary protein creatinine levels in urine,blood creatinine,triglyceride,total cholesterol,low-density lipoprotein,and high-density lipoprotein levels in serum,and triglyceride and total cholesterol levels in kidney tissue.HE and PAS staining were used to evaluate the pathological changes of mouse kidney.TBA kit was used to determine the content of total bile acid in serum of mice.The mRNA expression of sterol-regulatory element binding protein 1 and fatty acid synthase was detected by real-time fluorescence quantitative PCR.The mRNA and protein expression levels of farnesol X receptor(FXR)and G protein coupled bile acid receptor 5(TGR5)in mouse kidney tissues were detected by real-time fluorescent quantitative PCR,immunoblotting and immunohistochemistry,respectively.RESULTS Compared with the normal group,DN mice had higher blood glucose and blood lipid,increased renal lipid deposition,and impaired renal function.After treatment with Vac,Vac could alleviate lipid metabolism disorder and improve renal function in DN mice.The intestinal flora of DN mice was disordered,and the beneficial bacteria at the level of phylum and genus decreased,while the harmful bacteria increased.The intervention of Vac could significantly improve this situation.At the same time,Spearman correlation analysis also showed that the level of lipid metabolism in mice was significantly related to the intestinal flora.Compared with the normal group,the content of total bile acid in serum of the model group mice increased,and the expression of bile acid receptor FXR and TGR5 receptor decreased significantly.Vac could reduce the content of total bile acid and up regulate the expression of FXR and TGR5 receptor.CONCLUSION Vac can alleviate lipid deposition and improve renal function in DN mice by regulating the composition of intestinal flora and its metabolite bile acid.These results suggest that Vac may be an effective drug candidate to improve renal lipid deposition in patients with DN.
作者 于晓依 常畅 陈天笑 马琳春 陈欣雨 蔡维维 邱丽颖 YU Xiaoyi;CHANG Chang;CHEN Tianxiao;MA Linchun;CHEN Xinyu;CAI Weiwei;QIU Liying(Wuxi Medical College,Jiangnan University,Wuxi,Jiangsu,214122 P.R.China)
出处 《华西药学杂志》 CAS CSCD 北大核心 2024年第1期36-42,共7页 West China Journal of Pharmaceutical Sciences
关键词 王不留行黄酮苷 糖尿病肾病 空腹血糖 肾功能 脂质代谢 肠道菌群 胆汁酸 胆汁酸受体 Vaccarin Diabetes nephropathy Fasting blood glucose Kidney function Lipid metabolism Intestinal flora Bile acids Bile acid receptor
  • 相关文献

参考文献4

二级参考文献47

  • 1左芸芸,肖艳.糖尿病肾病中西医治疗研究进展[J].世界最新医学信息文摘,2019,0(98):135-136. 被引量:2
  • 2Xuefeng Xia,Heather Francis,Shannon Glaser,Gianfranco Alpini,Gene LeSage.Bile acid interactions with cholangiocytes[J].World Journal of Gastroenterology,2006,12(22):3553-3563. 被引量:16
  • 3Breyer MD, Bttinger E, Brosius FC, et al. Mouse models of dia- betic nephropathy [J]. J Am Soc Nephrol, 2005, 16( 1 ) :27 - 45.
  • 4Tan RJ, Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases[ J]. Am J Physiol Renal Physiol, 2012,302 ( 11 ) : 1351 - 1361.
  • 5Mikhail N. Incretin mimeties and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes [ J ]. Expert Opin Investig Drags, 2008, 17 (6) : 845 - 853.
  • 6Hattori Y, Jojima T, Tomizawa A, et al. A glucagon - like peptide - 1 ( GLP - 1 ) analogue, liraglutide, upregulates nitric ox- ide production and exerts anti - iifflammatory action in endothelial ceils [ J]. Diabetologia,2010,53 (10) :2256 - 2263.
  • 7Zhang S, Yang J, Li H, et al. Skimmin, a coumarin, suppresses the streptozotocin - induced diabetic nephropathy in wistar rats [ J ]. Eur J Pharmacol, 2012,692 ( 1 - 3 ) :78 - 83.
  • 8Zheng JM, Yao GH, Cheng Z, et al. PathQgenic role of mast cells in the development of diabetic nephropathy : a study of patients at different stages of the disease [ J]. Diabetologia, 2012,55 ( 3 ) : 801 -811.
  • 9王晓敏,罗颖,高增光.丹栀逍遥散对糖尿病抑郁大鼠肝组织IRS-2—PI3-K信号通路的作用[J].中华中医药学刊,2013,31(11):2450-2452. 被引量:11
  • 10刘芳,付平.糖尿病肾病的发生发展机制研究进展[J].中华肾病研究电子杂志,2013,2(4):32-35. 被引量:11

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部